Articles On Telix Pharmaceuticals (ASX:TLX)

ASX health stocks fall o.92% over past five days as US President Donald Trump renews tariff threat on pharmaceutical imports Morgans believes ASX’s biggest biotech CSL  is currently trading at levels significantly below fair value Cochlear...

Just when it seemed Australia had dodged a bullet with only a 10% tariff, Trump has unleashed a shock 200% tariff proposal on all imported pharmaceuticals. Listen to the HotCopper podcast for in-depth discussions and insights on all the...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) had a good session and charged higher. The benchmark index rose 0.6% to 8,589.2 points. Will the market build on this on Friday and end the week on a high? Here are five things to watch: ASX...

Highlights Australian share market dips with copper-exposed miners under pressure Trade-related tariff concerns weigh on broader resource sentiment Telix Pharmaceuticals outperforms with strong market momentum The Aust...

ASX closes lower on Wednesday, dropping 52.10 points or 0.61% to 8538.60 Seven of 11 ASX sectors were in the red as US President Donald Trump renewed his tariffs push Telix lifts on permanent US healthcare system code for PSMA PET imaging...

Well, it was a rather woeful Wednesday session for the S&P/ASX 200 Index (ASX: XJO) today, with investors decisively sending the markets lower. The ASX 200 spent all day in red territory and ended u...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record a disappointing decline. At the time of writing, the benchmark index is down 0.4% to 8,557.4 points. Four ASX shares that are not letting that hold them back to...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, July 9, 2025 /PRNewswire/ – Telix Pharmaceuticals Limited...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are having a strong session on Wednesday. In afternoon trade, the ASX 200 radiopharmaceuticals company's shares are up 7% to $25.71. This compares favourably to the performance of the benchmark AS...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Rudi Filapek-Vandyck (See also FNArena Talks and Ask FNArena further below). By Rudi Filap...

China Brain Project rolls out neuro-AI push Compumedics dual-helmet MEG lights up Tianjin labs ASX health stocks surge deeper into China   A few years back, China kicked off what might be one of the most ambitious science missions you’ve...

As we roll into a new financial year, investors and fund managers will be reflecting on their FY25. The past financial year proved to be a standout for many S&P/ASX 200 Index (ASX: XJO) companies.  In FY25, the ASX 200 Index rose...

Looking for a quality, under-the-radar S&P/ASX 200 Index (ASX: XJO) stock with strong forecast revenue growth? Then you may want to check out Telix Pharmaceuticals Ltd (ASX: TLX). Shares in the diagnostic and therapeutic product develop...

Highlights Flight Centre Travel Group Ltd (ASX:FLT) named among Bell Potter’s preferred equities Telix Pharmaceuticals Ltd (ASX:TLX) added to the broker’s long-term growth list Both companies selected based on valuation and...

With the new financial year just days away, now could be an opportune time to think about making some new additions to your investment portfolio. To help you narrow down your options, let's take a look at three ASX 200 shares that Bell Pott...

UBS reckons healthcare will fare better than any other ASX sector Bell Potter says Monash IVF has fertile recovery prospects Telix wins FDA usage expansion for prostate cancer imaging     Financial giant UBS has declared that enough is e...

While some companies grab headlines with flashy announcements, others simply execute, quietly benefiting from powerful long-term trends. These ASX 200 shares may not dominate daily newsfeeds, but they are positioned for durable growth thank...

I recently joined Adam Keily on Equity Mates for their Buy or Sell series. We kicked off the episode by discussing the market volatility experienced this year, including insights into how the Trump administration has influenced global marke...

Orthocell says its Remplir nerve device blitzes the stitches Singular Health inks US physician network deal Clarity clearly is undervalued, say brokers   Among other auspicious events, the 19th of June marks the end of slavery in the US,...

Investing with a five-year view requires more than just picking what's hot today. It is about identifying Australian shares with sustainable competitive advantages, scalable business models, and strong structural tailwinds. With that in min...

The S&P/ASX 200 Index (ASX: XJO) had a wild start to the week's trading, managing to record a slight rise despite stints in both positive and negative territory today. After initially spiking in va...

If you are lucky enough to have $5,000 to invest into ASX 200 shares, then it could be worth listening to what Bell Potter is saying about the three in this article. Here's why it is bullish on these names: Flight Centre Travel Group Ltd (...

Telix Pharmaceuticals Ltd (ASX: TLX) shares are rising on Thursday morning. At the time of writing, the radiopharmaceuticals company's shares are up 1% to $25.88. This follows the release of a wide-ranging update at its investor day. Telix...

Little Green Pharma reports record revenue and a return to profits Botanix raises $48 million of debt for its anti-sweating drug, Sofdra The DNA of Genetic Technologies soon will be … financial advice   Little Green Pharma’s (ASX:LGP) Eur...

Highlights ASX 200 advances, led by strength in financials, technology, and retail Tech stocks like NXT, WTC, and XRO post notable gains Gold stocks retreat, with EVN and NEM facing pressure The S&P/ASX 200 Index r...

Highlights ASX 200 closed lower influenced by geopolitical tensions and US market trading calendar Silver price surge and easing trade friction supported gains in mining and energy sectors Key resource stocks including WAF,...

Medical device makers – including ASX-listed heart plays – are the likely winners from the US healthcare chaos Painchek hopes for US device approval by September Mayne Pharma flags legal action over Cosette bid but also waves an olive bra...

“Your Stock Request” is a weekly video where we analyse share price charts for stocks on the Australian market (ASX) as requested by you! Email us at [email protected] with your stock request. Limit of one per person, no guarantee o...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and KYOTO, Japan, June 4, 2025 /PRNewswire/ – Telix Pharmac...

AI is reshaping microbiology in the labs Big Pharma taps Clever Culture’s APAS system Here are ASX biotechs with global health deals    Step into a modern microbiology lab today and you might notice something’s different. The culture plat...

Highlights ASX 200 posts slight gain in a subdued and low-volume session Energy sector gains on project approval, pharmaceuticals lift on US trade ruling Stocks with US and China exposure see limited movement despite tariff...

With some common types of cancers including breast and lung, therapies have developed at a rapid clip. The same can’t be said for pancreatic cancer, which is not among the most common tumours but ranks number one as the deadliest. Only 12%...

When it comes to managing your self-managed super fund (SMSF), the goal is clear: grow your wealth, protect your capital, and generate reliable returns over the long term. That's why choosing the right ASX shares for your SMSF is so importa...

Highlights Diverse performance across ASX 200 technology sector reflected by major players such as Catapult Group International (CAT), Nuix Limited (NXL) and Telix Pharmaceuticals (TLX) Catapult’s Vector 8 release, Nuix’s researc...

Highlights: SKS Technologies advances after securing a major data centre contract Graphite and gold stocks post broad gains amid global commodity developments Earlypay block trade and Perenti contract announcement stir secto...

AFT Pharmaceuticals boosts revenue, but profits still lag Telix Pharmaceuticals chair and CEO reflect on a prosperous 2024 – and promise more riches to come Dimerix’s pivotal trail passes another safety check   The bourse’s ‘forgotten’ dr...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia, May 20, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited...

Starting your investing journey can feel overwhelming — but it doesn't have to be. You don't need thousands of dollars or a background in finance to begin building wealth. In fact, with just $500, you can get started on the ASX with expos...

Highlights Core Lithium’s stock experiences strongest daily movement since a previous multi-year high Finniss Project study outlines lowered operational and capital costs with increased production ASX 200 continues upward tr...

US President Donald Trump has signed an executive order aimed at reducing drug costs for Americans, by up to 80% immediately. The move immediately hit Australia's pharmaceutical industry as 3 ASX pharmaceutical stocks crashed up to 10% s...

Compumedics’ MEG unit can scan adult and kid’s heads at the same time – a technically tricky task Microba’s comprehensive gut testing reveals all is not well in the tummy region Trump’s drug pricing blitz should be “immaterial”, says Telix...

We're now in the middle of May, and after a rocky start to the quarter, the ASX has rebounded strongly in recent weeks. While some investors may be wondering if they've missed the moment, smart investors know this simple truth: it's never t...

 Investors with a short position in wound care house Polynovo face a nervous wait Oz drug stocks partly recover after swooning yesterday on Trump drug-pricing edict Wellnex Life rediscovers its sales mojo, while Elinixol Wellness goes to t...

Highlights  ASX200 climbs amid global trade relief  Technology stocks lead, WiseTech surges  Gold miners slide as investors shift to equities  The Australian sharemarket made a strong upward move on renewed global optimism after t...

This article is part of the daily news updates from FNArena.com. Stay informed with the latest financial, business, and economic insights. Written by Admin MELBOURNE, Australia and INDIANAPOLIS, May 13, 2025 /PRNewswire/ — Telix Pharmac...

Highlights Mineral Resources (MIN) observed increased market activity amid global trade updates. Elixir Energy (EXR) advanced following a new strategic direction led by recent leadership changes. Biotechnology stocks, includ...

Some of the ASX’s best-known pharmaceutical companies – including Neuren, Telix and Clarity – have reported losses on Monday, after Donald Trump announced a plan to cut prescriptions drug prices by up to 80% via an executive order. The i...

Highlights ASX pharmaceutical stocks saw notable declines following U.S. policy comments. Trump's proposal aims to drastically cut U.S. prescription drug prices. Companies with U.S.-based pipelines or approvals felt the immediate mark...

Smart investors know that long-term wealth isn't built on hype — it is built by owning quality businesses with real earnings power, global opportunity, and the ability to compound growth over time. Right now, a handful of ASX 200 shares a...

A 10-bagger describes an investment that has increased 10 times in value.  The term '10-bagger' was first coined by Fund Manager Peter Lynch in his book One Up On Wall Street. Landing one of these is every investor's dream.  Which s...